Neo Neopar Mr Tablet 10

Neo Neopar MR Tablet may interact with the following medicines:

• Anticoagulants and antiplatelet medicines (e.g., warfarin, heparin and clopidogrel): Nimesulide may increase bleeding risk by affecting platelet function and the gastrointestinal lining. Concurrent use may increase the likelihood of gastrointestinal or other bleeding and requires medical supervision.
• Other NSAIDs (e.g., ibuprofen, diclofenac and naproxen): Taking nimesulide with other NSAIDs may increase the risk of stomach ulcers, gastrointestinal bleeding and kidney injury. Combining these medicines should generally be avoided because it increases adverse effects without providing a clear additional benefit.
• Corticosteroids (e.g., prednisolone and dexamethasone): Concurrent use with nimesulide may increase the risk of gastrointestinal ulcers and bleeding. Patients receiving both medicines may require careful monitoring and additional protective treatment.
• Sedatives and central nervous system depressants (e.g., diazepam, alprazolam and opioid painkillers): Chlorzoxazone may enhance the sedative effects of these medicines, causing excessive drowsiness, dizziness or impaired coordination. Combining them may increase the risk of falls and accidents and, with some depressants, breathing problems.
• ACE inhibitors (e.g., enalapril), ARBs (e.g., losartan) and diuretics (e.g., furosemide): Nimesulide may reduce their effectiveness and increase the risk of kidney injury, particularly in older or dehydrated patients.
• Methotrexate: NSAIDs such as nimesulide may reduce the renal elimination of methotrexate, potentially increasing its concentration in the blood. This may increase the risk of methotrexate toxicity, including bone marrow suppression and kidney damage.
• Lithium: Nimesulide may reduce lithium clearance through the kidneys, increasing lithium concentrations in the blood. This may raise the risk of toxicity, including tremors, vomiting, confusion and impaired coordination.
• Cyclosporine and tacrolimus: These immunosuppressants can affect kidney function, and combining them with nimesulide may increase the risk of kidney injury. Patients taking these medicines may require close monitoring of kidney function.

None

Neo Neopar MR Tablet may interact with the following conditions:

• Peptic Ulcers or Gastrointestinal Bleeding: Nimesulide may reduce protective prostaglandins in the stomach and intestinal lining, increasing the risk of ulcers and bleeding. Patients with active ulcers or gastrointestinal bleeding should not take this medicine because it may worsen their condition.
• Heart Disease or High Blood Pressure: Nimesulide may cause fluid retention, increase blood pressure and worsen certain cardiovascular conditions. Patients with heart disease, heart failure or uncontrolled hypertension may have an increased risk of complications.
• Asthma Associated With NSAID Sensitivity: Nimesulide may trigger bronchospasm or allergic reactions in patients who have previously experienced asthma attacks after taking aspirin or other NSAIDs. Such patients should avoid this medicine because it may cause severe breathing difficulties.

The dose and duration of Neo Neopar MR Tablet depend on the severity of pain, muscle spasms and the patient's medical condition. Take the daily dose only as your doctor prescribes.

An overdose may cause nausea, vomiting, severe drowsiness, dizziness, gastrointestinal bleeding, kidney injury or serious liver damage. Seek immediate medical attention if an overdose is suspected, even if symptoms are initially mild.

If you miss a dose, take it as soon as you remember unless it is nearly time for the next scheduled dose. Skip the missed dose if the next one is due soon. Do not take a double dose.